StockData
Compass Therapeutics, Inc. logo

Compass Therapeutics, Inc. (CMPX) income statement

CMPXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$0.61+0.00 (+0.71%)

Close on Nov 18, 2026Market cap $110.03MP/E –Yield –

See a number that looks wrong?